An independent intelligence board aggregating credible research, preprints, clinical findings, biohacking experiments, and community discussions on therapeutic peptides, longevity science, and evidence-based anti-aging. Stories are scored for relevance, credibility, novelty, momentum, and practicality so the most important findings surface first.
Someone on a forum asked whether people have switched directly from Mounjaro (tirzepatide) at a 7.5 mg dose to a generic semaglutide at the 2.4 mg dose, after hitting a weight-loss plateau. They say they lost about 15 kg over 3.5 months on Mounjaro, are now stalled, and are considering swapping drugs because their cravings are creeping back. The question is basically: has anyone done this direct swap, and what happened? Tirzepatide (brand name Mounjaro) and semaglutide (brand names Ozempic, Wegovy; generics are becoming available) are different but related medicines. Both are injectable drugs that act on hormones that control appetite. Semaglutide mostly mimics a gut hormone called GLP-1 (which signals fullness and slows stomach emptying). Tirzepatide hits GLP-1 and also GIP (another hormone), so it affects appetite and also how the body handles blood sugar in slightly different ways. They’re not the same drug, so switching between them is not simply swapping equivalent doses. The original post is an individual user report — not a formal study. That matters because experiences vary. Clinical trials have shown both drugs can produce substantial weight loss, but tirzepatide has tended to show larger average losses than semaglutide at the approved doses in head-to-head trials. Plateaus are common with any weight-loss medication: the initial drop can slow or stop as your body adapts. A direct switch might help some people regain momentum, but it can also produce different side effects or less effect depending on how your body responds. The forum poster didn’t include details about medical supervision, blood tests, or other health conditions, so the anecdote can’t tell us what will happen broadly. Why this matters: people using these medicines want to know practical options when progress stalls or when cost and availability change. Semaglutide 2.4 mg (the higher weight-loss dose) is approved for chronic weight management and may be cheaper or more available as a generic. Switching could be attractive for cost or tolerability reasons. But the two drugs can work differently for different people, so what helps one person may not help another. This is especially relevant if you have diabetes, heart disease, or other conditions where glucose control matters — the choice of drug can change blood sugar behavior and might require different monitoring or dose adjustments. Caveats and risks: don’t switch on your own. These are prescription medications with possible side effects like nausea, vomiting, diarrhea, low blood sugar (especially if you take diabetes meds), and, rarely, pancreatitis or gallbladder issues. Stopping one drug and starting another can change side effects and metabolic effects. Your prescriber should consider your medical history, current medications, lab results, and dosing schedules. Availability and regulatory approvals differ by country; “generic” labeling doesn’t mean identical effect or interchangeability without guidance. If cost is the issue, ask your clinician about tapering strategies, dose adjustments, or supervised switching. Bottom line: a direct switch is something some people try, but it’s personal and should be done with medical advice — what worked for one forum poster doesn’t predict your result.
Source: r/Semaglutide